enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 8-K
Filing Date: 15 Jun 2026Report Date: 13 Jun 2026
Accepted: 15 Jun 2026 07:14 a.m.
Accession Number: 0001193125-26-270384
File Number: 001-41854
Film Number: 261089199
Items: 2.02,2.05,5.02,7.01,8.01,9.01
Documents
Primary Document: 8-K
Accepted: 15 Jun 2026 07:14 a.m.
0001193125-26-270384-index-headers.html
Last Modified: 15 Jun 2026 07:14 a.m.
0001193125-26-270384-index.html
Last Modified: 15 Jun 2026 07:14 a.m.
0001193125-26-270384.txt
Last Modified: 15 Jun 2026 07:14 a.m.
0001193125-26-270384-xbrl.zip
Last Modified: 15 Jun 2026 07:14 a.m.
engn-20260613.xsd
Last Modified: 15 Jun 2026 07:14 a.m.
engn-20260613_htm.xml
Last Modified: 15 Jun 2026 07:14 a.m.
engn-ex99_1.htm
Last Modified: 15 Jun 2026 07:14 a.m.
FilingSummary.xml
Last Modified: 15 Jun 2026 07:14 a.m.
img7790613_0.jpg
Last Modified: 15 Jun 2026 07:14 a.m.
MetaLinks.json
Last Modified: 15 Jun 2026 07:14 a.m.
R1.htm
Last Modified: 15 Jun 2026 07:14 a.m.
report.css
Last Modified: 15 Jun 2026 07:14 a.m.
Show.js
Last Modified: 15 Jun 2026 07:14 a.m.